Info

The NACCHO Podcast Series

The NACCHO Podcast series provides public health professionals with in-depth interviews featuring some of the field's top officials. Listeners can also learn the latest news from Washington, DC with our monthly "Podcast From Washington."
RSS Feed Subscribe in Apple Podcasts
The NACCHO Podcast Series
2024
November
October
September
August
July
June
May
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
February


2022
December
October
September
June
May
April
March
February
January


2021
December
November
October
September
July
June
May
April
March
February
January


2020
December
November
October
September
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May
April
March
February
January


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Oct 8, 2021

In this week’s episode of Podcast from Washington, NACCHO Government Affairs team members Ian Goldstein and Adriane Casalotti discuss the agreement reached by Congress to lift the debt ceiling until December. They also discuss emergency authorization use of the Pfizer/BioNTech vaccine for children ages 5 – 11, new rules for the Title X family planning program, and the implications of the Administration’s proposal to ramp up at-home rapid testing. 

Later in the program, Ian speaks with Dr. Sema Sgaier, co-founder and CEO of Surgo Ventures, a dynamic action tank that combines philanthropy with data scientists, behavioral scientists, and technologists to solve some of the most intractable health problems and develop scalable solutions to move them to action. Dr. Sgaier talks about how Surgo developed surveys on projected vaccination rates among adults. 

0 Comments
Adding comments is not available at this time.